Literature DB >> 16521283

Decision tools for life support: a review and policy analysis.

M Giacomini1, D Cook, D DeJean, R Shaw, E Gedge.   

Abstract

OBJECTIVE: To identify, describe, and compare published documents intended to guide decisions about the administration, withholding, or withdrawal of life support in critical care.
DESIGN: Review article. SETTING AND SOURCES: Publicly available, English-language guidelines or decision tools for life support, identified through systematic literature search.
MEASUREMENTS AND MAIN RESULTS: Forty-nine documents were included and coded for authorship, source, development methodology, format, and positions taken on 12 common life-support issues. Sources were independent academics (n=21, 43%), professional organizations (n=19, 44%), and provider organizations. Eighteen documents (37%) described no development method. Twenty-three (47%) were produced collectively (e.g., by committees or consensus conference), 7 (14%) mentioned a literature review, and 2 (4%) were based upon the author's professional experience. Tools differed in format and focus; we characterize three types as decision schemas (involving clinical practice algorithms; n=7, 14%), decision guides (reviewing legal or professional positions; n=29, 59%), and decision counsels (more discursive and focusing typically on ethical issues; n=13, 27%). Tools addressed 12 common life-support issues: advance directives (67%), resource considerations (51%), ICU discharge criteria (27%), ICU admission criteria (16%), whether withholding differs from withdrawing life support (59%), whether nutrition and hydration decisions are different from decisions about other types of life support (61%), euthanasia (49%), double effect (47%), brain death (35%), special considerations for patients in a persistent vegetative state (51%), potential organ donors (12%), and pregnant patients (10%). Positions on these key life-support issues varied.
CONCLUSIONS: Published tools for guiding life-support decisions vary widely in their genesis, authorship, format, focus, and practicality. They also differ in their attention to, and positions on, key life-support dilemmas. Future research on decision tools should focus on how users interpret and apply the messages in these tools and their impacts on practice, quality of care, participant experiences, and outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 16521283     DOI: 10.1097/01.ccm.0000201904.92483.c6

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Health technology assessment in critical care.

Authors:  Damon C Scales; Andreas Laupacis
Journal:  Intensive Care Med       Date:  2007-10-20       Impact factor: 17.440

2.  Content analysis of euthanasia policies of nursing homes in Flanders (Belgium).

Authors:  Joke Lemiengre; Bernadette Dierckx de Casterlé; Yvonne Denier; Paul Schotsmans; Chris Gastmans
Journal:  Med Health Care Philos       Date:  2009-01-11

Review 3.  Withholding and withdrawing life support in critical care settings: ethical issues concerning consent.

Authors:  E Gedge; M Giacomini; D Cook
Journal:  J Med Ethics       Date:  2007-04       Impact factor: 2.903

4.  A costly separation between withdrawing and withholding treatment in intensive care.

Authors:  Dominic Wilkinson; Julian Savulescu
Journal:  Bioethics       Date:  2012-07-05       Impact factor: 1.898

5.  Pediatric Resident Experience Caring for Children at the End of Life in a Children's Hospital.

Authors:  Amy Trowbridge; Tara Bamat; Heather Griffis; Eric McConathey; Chris Feudtner; Jennifer K Walter
Journal:  Acad Pediatr       Date:  2019-07-31       Impact factor: 3.107

6.  Hemodialysis as a life-sustaining treatment at the end of life.

Authors:  Sung Joon Shin; Jae Hang Lee
Journal:  Kidney Res Clin Pract       Date:  2018-06-30

7.  Inclusion of ethical issues in dementia guidelines: a thematic text analysis.

Authors:  Hannes Knüppel; Marcel Mertz; Martina Schmidhuber; Gerald Neitzke; Daniel Strech
Journal:  PLoS Med       Date:  2013-08-13       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.